Loading…
Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis
Ketoconazole at 200 mg/kg dose has been found to exert marginal antimalarial action against multidrug resistant (MDR) Plasmodium yoelii nigeriensis ( P. yoelii nigeriensis) in Swiss mice with 25% protection (2/8 mice) while at lower Ketoconazole dose i.e., 75–100 mg/kg, 14.28% mice were protected. M...
Saved in:
Published in: | Experimental parasitology 2004-07, Vol.107 (3), p.115-119 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353 |
---|---|
cites | cdi_FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353 |
container_end_page | 119 |
container_issue | 3 |
container_start_page | 115 |
container_title | Experimental parasitology |
container_volume | 107 |
creator | Awasthi, Aradhana Dutta, G.P. Bhakuni, Vinod Tripathi, Renu |
description | Ketoconazole at 200
mg/kg dose has been found to exert marginal antimalarial action against multidrug resistant (MDR)
Plasmodium yoelii nigeriensis (
P. yoelii nigeriensis) in Swiss mice with 25% protection (2/8 mice) while at lower Ketoconazole dose i.e., 75–100
mg/kg, 14.28% mice were protected. Mefloquine (MFQ) (at 8 and 16
mg/kg) exerted suppressive action against MDR
P. yoelii nigeriensis resulting in 25 and 14.28% protection of mice respectively. Combined treatment with Ketoconazole and mefloquine resulted in protection of 5/6 mice (83.33%) at MFQ 4
mg/kg
+
Ketoconazole 100
mg/kg dose, 7/8 (87.5%) mice at MFQ 8
mg/kg
+
Ketoconazole 20
mg/kg dose and 5/7 (71.42%) mice at MFQ 16
mg/kg
+
Ketoconazole 25
mg/kg dose and 5/6 (83.33%) mice at MFQ 16
mg/kg
+
Ketoconazole 100
mg/kg dose. Ketoconazole has been found to enhance the protective effect of mefloquine against MFQ resistant
P. yoelii nigeriensis resulting in 66–88% protection of the mice treated with the appropriate combinations. The combination also increased suppression of parasitaemia at different times. The Ketoconazole combination with MFQ significantly increased the mean survival time of the treated mice compared to individual drugs alone. The study shows that Ketoconazole when administered with MFQ exerts bio-enhancing action against mefloquine resistance of MDR
P. yoelii nigeriensis. |
doi_str_mv | 10.1016/j.exppara.2004.06.001 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66874013</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014489404000992</els_id><sourcerecordid>17829727</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353</originalsourceid><addsrcrecordid>eNqFkUuLFDEURoMoTjv6E5Ta6K7Km0flsRIZfMGAIroOqdStIW2q0ibVg-OvN00XznJWF8L5ci_nI-QlhY4ClW_3Hf45HFx2HQMQHcgOgD4iOwoGWiaEeUx29UW0QhtxQZ6VsgcATZl4Si5ozyU3XO5I-I4llNUtHpuMt5iLi43za0hLk6bmF67Jp8X9TREbd-PCUtZmximm38ewnCL_05X-Fl2Z0xiOc3OXMIbQLOEGc8ClUs_Jk8nFgi-2eUl-fvzw4-pze_3105er99et51ytrZaD4QyMF1IwVIo6Pri-51pRHLXsqaLSDZPkSgvhDIxsGqTmkzcKB8V7fknenP895HokltXOoXiM0S2YjsVKqZUAyh8EqdLMKKYq2J9Bn1MpGSd7yGF2-c5SsKcy7N5uZdhTGRakrepr7tW24DjMON6nNvsVeL0BrngXp1xFhnLPSco1o1C5d2cOq7fbgNkWX6V6HENGv9oxhQdO-Qek_av5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17829727</pqid></control><display><type>article</type><title>Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis</title><source>Elsevier</source><creator>Awasthi, Aradhana ; Dutta, G.P. ; Bhakuni, Vinod ; Tripathi, Renu</creator><creatorcontrib>Awasthi, Aradhana ; Dutta, G.P. ; Bhakuni, Vinod ; Tripathi, Renu</creatorcontrib><description>Ketoconazole at 200
mg/kg dose has been found to exert marginal antimalarial action against multidrug resistant (MDR)
Plasmodium yoelii nigeriensis (
P. yoelii nigeriensis) in Swiss mice with 25% protection (2/8 mice) while at lower Ketoconazole dose i.e., 75–100
mg/kg, 14.28% mice were protected. Mefloquine (MFQ) (at 8 and 16
mg/kg) exerted suppressive action against MDR
P. yoelii nigeriensis resulting in 25 and 14.28% protection of mice respectively. Combined treatment with Ketoconazole and mefloquine resulted in protection of 5/6 mice (83.33%) at MFQ 4
mg/kg
+
Ketoconazole 100
mg/kg dose, 7/8 (87.5%) mice at MFQ 8
mg/kg
+
Ketoconazole 20
mg/kg dose and 5/7 (71.42%) mice at MFQ 16
mg/kg
+
Ketoconazole 25
mg/kg dose and 5/6 (83.33%) mice at MFQ 16
mg/kg
+
Ketoconazole 100
mg/kg dose. Ketoconazole has been found to enhance the protective effect of mefloquine against MFQ resistant
P. yoelii nigeriensis resulting in 66–88% protection of the mice treated with the appropriate combinations. The combination also increased suppression of parasitaemia at different times. The Ketoconazole combination with MFQ significantly increased the mean survival time of the treated mice compared to individual drugs alone. The study shows that Ketoconazole when administered with MFQ exerts bio-enhancing action against mefloquine resistance of MDR
P. yoelii nigeriensis.</description><identifier>ISSN: 0014-4894</identifier><identifier>EISSN: 1090-2449</identifier><identifier>DOI: 10.1016/j.exppara.2004.06.001</identifier><identifier>PMID: 15363936</identifier><identifier>CODEN: EXPAAA</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Animals ; Antimalarials - pharmacology ; Antimalarials - therapeutic use ; Biological and medical sciences ; Dose-Response Relationship, Drug ; Drug Resistance, Multiple - drug effects ; Drug Therapy, Combination ; Fundamental and applied biological sciences. Psychology ; Ketoconazole - pharmacology ; Ketoconazole - therapeutic use ; Life cycle. Host-agent relationship. Pathogenesis ; Malaria - drug therapy ; Malaria - mortality ; Malaria - parasitology ; Mefloquine - pharmacology ; Mefloquine - therapeutic use ; Mice ; Parasitemia - drug therapy ; Parasitemia - mortality ; Parasitemia - parasitology ; Plasmodium yoelii - drug effects ; Plasmodium yoelii nigeriensis ; Protozoa ; Survival Rate</subject><ispartof>Experimental parasitology, 2004-07, Vol.107 (3), p.115-119</ispartof><rights>2004 Elsevier Inc.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353</citedby><cites>FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16138210$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15363936$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Awasthi, Aradhana</creatorcontrib><creatorcontrib>Dutta, G.P.</creatorcontrib><creatorcontrib>Bhakuni, Vinod</creatorcontrib><creatorcontrib>Tripathi, Renu</creatorcontrib><title>Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis</title><title>Experimental parasitology</title><addtitle>Exp Parasitol</addtitle><description>Ketoconazole at 200
mg/kg dose has been found to exert marginal antimalarial action against multidrug resistant (MDR)
Plasmodium yoelii nigeriensis (
P. yoelii nigeriensis) in Swiss mice with 25% protection (2/8 mice) while at lower Ketoconazole dose i.e., 75–100
mg/kg, 14.28% mice were protected. Mefloquine (MFQ) (at 8 and 16
mg/kg) exerted suppressive action against MDR
P. yoelii nigeriensis resulting in 25 and 14.28% protection of mice respectively. Combined treatment with Ketoconazole and mefloquine resulted in protection of 5/6 mice (83.33%) at MFQ 4
mg/kg
+
Ketoconazole 100
mg/kg dose, 7/8 (87.5%) mice at MFQ 8
mg/kg
+
Ketoconazole 20
mg/kg dose and 5/7 (71.42%) mice at MFQ 16
mg/kg
+
Ketoconazole 25
mg/kg dose and 5/6 (83.33%) mice at MFQ 16
mg/kg
+
Ketoconazole 100
mg/kg dose. Ketoconazole has been found to enhance the protective effect of mefloquine against MFQ resistant
P. yoelii nigeriensis resulting in 66–88% protection of the mice treated with the appropriate combinations. The combination also increased suppression of parasitaemia at different times. The Ketoconazole combination with MFQ significantly increased the mean survival time of the treated mice compared to individual drugs alone. The study shows that Ketoconazole when administered with MFQ exerts bio-enhancing action against mefloquine resistance of MDR
P. yoelii nigeriensis.</description><subject>Animals</subject><subject>Antimalarials - pharmacology</subject><subject>Antimalarials - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Resistance, Multiple - drug effects</subject><subject>Drug Therapy, Combination</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Ketoconazole - pharmacology</subject><subject>Ketoconazole - therapeutic use</subject><subject>Life cycle. Host-agent relationship. Pathogenesis</subject><subject>Malaria - drug therapy</subject><subject>Malaria - mortality</subject><subject>Malaria - parasitology</subject><subject>Mefloquine - pharmacology</subject><subject>Mefloquine - therapeutic use</subject><subject>Mice</subject><subject>Parasitemia - drug therapy</subject><subject>Parasitemia - mortality</subject><subject>Parasitemia - parasitology</subject><subject>Plasmodium yoelii - drug effects</subject><subject>Plasmodium yoelii nigeriensis</subject><subject>Protozoa</subject><subject>Survival Rate</subject><issn>0014-4894</issn><issn>1090-2449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqFkUuLFDEURoMoTjv6E5Ta6K7Km0flsRIZfMGAIroOqdStIW2q0ibVg-OvN00XznJWF8L5ci_nI-QlhY4ClW_3Hf45HFx2HQMQHcgOgD4iOwoGWiaEeUx29UW0QhtxQZ6VsgcATZl4Si5ozyU3XO5I-I4llNUtHpuMt5iLi43za0hLk6bmF67Jp8X9TREbd-PCUtZmximm38ewnCL_05X-Fl2Z0xiOc3OXMIbQLOEGc8ClUs_Jk8nFgi-2eUl-fvzw4-pze_3105er99et51ytrZaD4QyMF1IwVIo6Pri-51pRHLXsqaLSDZPkSgvhDIxsGqTmkzcKB8V7fknenP895HokltXOoXiM0S2YjsVKqZUAyh8EqdLMKKYq2J9Bn1MpGSd7yGF2-c5SsKcy7N5uZdhTGRakrepr7tW24DjMON6nNvsVeL0BrngXp1xFhnLPSco1o1C5d2cOq7fbgNkWX6V6HENGv9oxhQdO-Qek_av5</recordid><startdate>200407</startdate><enddate>200407</enddate><creator>Awasthi, Aradhana</creator><creator>Dutta, G.P.</creator><creator>Bhakuni, Vinod</creator><creator>Tripathi, Renu</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>200407</creationdate><title>Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis</title><author>Awasthi, Aradhana ; Dutta, G.P. ; Bhakuni, Vinod ; Tripathi, Renu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Antimalarials - pharmacology</topic><topic>Antimalarials - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Resistance, Multiple - drug effects</topic><topic>Drug Therapy, Combination</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Ketoconazole - pharmacology</topic><topic>Ketoconazole - therapeutic use</topic><topic>Life cycle. Host-agent relationship. Pathogenesis</topic><topic>Malaria - drug therapy</topic><topic>Malaria - mortality</topic><topic>Malaria - parasitology</topic><topic>Mefloquine - pharmacology</topic><topic>Mefloquine - therapeutic use</topic><topic>Mice</topic><topic>Parasitemia - drug therapy</topic><topic>Parasitemia - mortality</topic><topic>Parasitemia - parasitology</topic><topic>Plasmodium yoelii - drug effects</topic><topic>Plasmodium yoelii nigeriensis</topic><topic>Protozoa</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Awasthi, Aradhana</creatorcontrib><creatorcontrib>Dutta, G.P.</creatorcontrib><creatorcontrib>Bhakuni, Vinod</creatorcontrib><creatorcontrib>Tripathi, Renu</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental parasitology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Awasthi, Aradhana</au><au>Dutta, G.P.</au><au>Bhakuni, Vinod</au><au>Tripathi, Renu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis</atitle><jtitle>Experimental parasitology</jtitle><addtitle>Exp Parasitol</addtitle><date>2004-07</date><risdate>2004</risdate><volume>107</volume><issue>3</issue><spage>115</spage><epage>119</epage><pages>115-119</pages><issn>0014-4894</issn><eissn>1090-2449</eissn><coden>EXPAAA</coden><abstract>Ketoconazole at 200
mg/kg dose has been found to exert marginal antimalarial action against multidrug resistant (MDR)
Plasmodium yoelii nigeriensis (
P. yoelii nigeriensis) in Swiss mice with 25% protection (2/8 mice) while at lower Ketoconazole dose i.e., 75–100
mg/kg, 14.28% mice were protected. Mefloquine (MFQ) (at 8 and 16
mg/kg) exerted suppressive action against MDR
P. yoelii nigeriensis resulting in 25 and 14.28% protection of mice respectively. Combined treatment with Ketoconazole and mefloquine resulted in protection of 5/6 mice (83.33%) at MFQ 4
mg/kg
+
Ketoconazole 100
mg/kg dose, 7/8 (87.5%) mice at MFQ 8
mg/kg
+
Ketoconazole 20
mg/kg dose and 5/7 (71.42%) mice at MFQ 16
mg/kg
+
Ketoconazole 25
mg/kg dose and 5/6 (83.33%) mice at MFQ 16
mg/kg
+
Ketoconazole 100
mg/kg dose. Ketoconazole has been found to enhance the protective effect of mefloquine against MFQ resistant
P. yoelii nigeriensis resulting in 66–88% protection of the mice treated with the appropriate combinations. The combination also increased suppression of parasitaemia at different times. The Ketoconazole combination with MFQ significantly increased the mean survival time of the treated mice compared to individual drugs alone. The study shows that Ketoconazole when administered with MFQ exerts bio-enhancing action against mefloquine resistance of MDR
P. yoelii nigeriensis.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>15363936</pmid><doi>10.1016/j.exppara.2004.06.001</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-4894 |
ispartof | Experimental parasitology, 2004-07, Vol.107 (3), p.115-119 |
issn | 0014-4894 1090-2449 |
language | eng |
recordid | cdi_proquest_miscellaneous_66874013 |
source | Elsevier |
subjects | Animals Antimalarials - pharmacology Antimalarials - therapeutic use Biological and medical sciences Dose-Response Relationship, Drug Drug Resistance, Multiple - drug effects Drug Therapy, Combination Fundamental and applied biological sciences. Psychology Ketoconazole - pharmacology Ketoconazole - therapeutic use Life cycle. Host-agent relationship. Pathogenesis Malaria - drug therapy Malaria - mortality Malaria - parasitology Mefloquine - pharmacology Mefloquine - therapeutic use Mice Parasitemia - drug therapy Parasitemia - mortality Parasitemia - parasitology Plasmodium yoelii - drug effects Plasmodium yoelii nigeriensis Protozoa Survival Rate |
title | Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A38%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resistance%20reversal%20action%20of%20ketoconazole%20against%20mefloquine%20resistance%20of%20Plasmodium%20yoelii%20nigeriensis&rft.jtitle=Experimental%20parasitology&rft.au=Awasthi,%20Aradhana&rft.date=2004-07&rft.volume=107&rft.issue=3&rft.spage=115&rft.epage=119&rft.pages=115-119&rft.issn=0014-4894&rft.eissn=1090-2449&rft.coden=EXPAAA&rft_id=info:doi/10.1016/j.exppara.2004.06.001&rft_dat=%3Cproquest_cross%3E17829727%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17829727&rft_id=info:pmid/15363936&rfr_iscdi=true |